Literature DB >> 20644163

STAT5 is critical to maintain effector CD8+ T cell responses.

Pulak Tripathi1, Sema Kurtulus, Sara Wojciechowski, Allyson Sholl, Kasper Hoebe, Suzanne C Morris, Fred D Finkelman, H Leighton Grimes, David A Hildeman.   

Abstract

During an immune response, most effector T cells die, whereas some are maintained and become memory T cells. Factors controlling the survival of effector CD4(+) and CD8(+) T cells remain unclear. In this study, we assessed the role of IL-7, IL-15, and their common signal transducer, STAT5, in maintaining effector CD4(+) and CD8(+) T cell responses. Following viral infection, IL-15 was required to maintain a subpopulation of effector CD8(+) T cells expressing high levels of killer cell lectin-like receptor subfamily G, member 1 (KLRG1), and lower levels of CD127, whereas IL-7 and IL-15 acted together to maintain KLRG1(low)CD127(high) CD8(+) effector T cells. In contrast, effector CD4(+) T cell numbers were not affected by the individual or combined loss of IL-15 and IL-7. Both IL-7 and IL-15 drove phosphorylation of STAT5 within effector CD4(+) and CD8(+) T cells. When STAT5 was deleted during the course of infection, both KLRG1(high)CD127(low) and KLRG1(low)CD127(high) CD8(+) T cells were lost, although effector CD4(+) T cell populations were maintained. Furthermore, STAT5 was required to maintain expression of Bcl-2 in effector CD8(+), but not CD4(+), T cells. Finally, IL-7 and IL-15 required STAT5 to induce Bcl-2 expression and to maintain effector CD8(+) T cells. Together, these data demonstrate that IL-7 and IL-15 signaling converge on STAT5 to maintain effector CD8(+) T cell responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20644163      PMCID: PMC2991082          DOI: 10.4049/jimmunol.1000842

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  Jak3 selectively regulates Bax and Bcl-2 expression to promote T-cell development.

Authors:  R Wen; D Wang; C McKay; K D Bunting; J C Marine; E F Vanin; G P Zambetti; S J Korsmeyer; J N Ihle; J L Cleveland
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

2.  Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation.

Authors:  Yongzhi Cui; Greg Riedlinger; Keiko Miyoshi; Wei Tang; Cuiling Li; Chu-Xia Deng; Gertraud W Robinson; Lothar Hennighausen
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

3.  CD4 T cell-dependent CD8 T cell maturation.

Authors:  Aaruni Khanolkar; Michael J Fuller; Allan J Zajac
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

4.  The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5.

Authors:  J D Lord; B C McIntosh; P D Greenberg; B H Nelson
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

5.  Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells.

Authors:  J Z Qin; C L Zhang; J Kamarashev; R Dummer; G Burg; U Döbbeling
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

6.  Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice.

Authors:  Klaus Okkenhaug; Antonio Bilancio; Géraldine Farjot; Helen Priddle; Sara Sancho; Emma Peskett; Wayne Pearce; Stephen E Meek; Ashreena Salpekar; Michael D Waterfield; Andrew J H Smith; Bart Vanhaesebroeck
Journal:  Science       Date:  2002-07-18       Impact factor: 47.728

7.  The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15.

Authors:  J X Lin; T S Migone; M Tsang; M Friedmann; J A Weatherbee; L Zhou; A Yamauchi; E T Bloom; J Mietz; S John
Journal:  Immunity       Date:  1995-04       Impact factor: 31.745

8.  Distinct regions of the interleukin-7 receptor regulate different Bcl2 family members.

Authors:  Qiong Jiang; Wen Qing Li; Robert R Hofmeister; Howard A Young; David R Hodge; Jonathan R Keller; Annette R Khaled; Scott K Durum
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

9.  Anti-apoptotic signaling by the interleukin-2 receptor reveals a function for cytoplasmic tyrosine residues within the common gamma (gamma c) receptor subunit.

Authors:  Matthew J Lindemann; Marta Benczik; Sarah L Gaffen
Journal:  J Biol Chem       Date:  2003-01-12       Impact factor: 5.157

10.  Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.

Authors:  Susan M Kaech; Joyce T Tan; E John Wherry; Bogumila T Konieczny; Charles D Surh; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-11-16       Impact factor: 25.606

View more
  64 in total

1.  The MicroRNA miR-191 Supports T Cell Survival Following Common γ Chain Signaling.

Authors:  Erik Allen Lykken; Qi-Jing Li
Journal:  J Biol Chem       Date:  2016-09-15       Impact factor: 5.157

2.  Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.

Authors:  Shannon L Maude; Sibasish Dolai; Cristina Delgado-Martin; Tiffaney Vincent; Alissa Robbins; Arthavan Selvanathan; Theresa Ryan; Junior Hall; Andrew C Wood; Sarah K Tasian; Stephen P Hunger; Mignon L Loh; Charles G Mullighan; Brent L Wood; Michelle L Hermiston; Stephan A Grupp; Richard B Lock; David T Teachey
Journal:  Blood       Date:  2015-02-02       Impact factor: 22.113

3.  Differential expression of Ly6C and T-bet distinguish effector and memory Th1 CD4(+) cell properties during viral infection.

Authors:  Heather D Marshall; Anmol Chandele; Yong Woo Jung; Hailong Meng; Amanda C Poholek; Ian A Parish; Rachel Rutishauser; Weiguo Cui; Steven H Kleinstein; Joe Craft; Susan M Kaech
Journal:  Immunity       Date:  2011-10-20       Impact factor: 31.745

Review 4.  Dying to protect: cell death and the control of T-cell homeostasis.

Authors:  Kun-Po Li; Sharmila Shanmuganad; Kaitlin Carroll; Jonathan D Katz; Michael B Jordan; David A Hildeman
Journal:  Immunol Rev       Date:  2017-05       Impact factor: 12.988

5.  Stable inhibitory activity of regulatory T cells requires the transcription factor Helios.

Authors:  Hye-Jung Kim; R Anthony Barnitz; Taras Kreslavsky; Flavian D Brown; Howell Moffett; Madeleine E Lemieux; Yasemin Kaygusuz; Torsten Meissner; Tobias A W Holderried; Susan Chan; Philippe Kastner; W Nicholas Haining; Harvey Cantor
Journal:  Science       Date:  2015-10-16       Impact factor: 47.728

6.  Regulation of tissue-dependent differences in CD8+ T cell apoptosis during viral infection.

Authors:  Varun N Kapoor; Hyun Mu Shin; Ok Hyun Cho; Leslie J Berg; Joonsoo Kang; Raymond M Welsh
Journal:  J Virol       Date:  2014-06-18       Impact factor: 5.103

7.  The neonatal microenvironment programs innate γδ T cells through the transcription factor STAT5.

Authors:  Darshana Kadekar; Rasmus Agerholm; John Rizk; Heidi A Neubauer; Tobias Suske; Barbara Maurer; Monica Torrellas Viñals; Elena M Comelli; Amel Taibi; Richard Moriggl; Vasileios Bekiaris
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

8.  Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells.

Authors:  Wenting Huang; Kritika Kachapati; David Adams; Yuehong Wu; Patrick S C Leung; Guo-Xiang Yang; Weici Zhang; Aftab A Ansari; Richard A Flavell; M Eric Gershwin; William M Ridgway
Journal:  J Autoimmun       Date:  2014-02-18       Impact factor: 7.094

9.  Disparate roles for STAT5 in primary and secondary CTL responses.

Authors:  Diana M Mitchell; Matthew A Williams
Journal:  J Immunol       Date:  2013-02-25       Impact factor: 5.422

10.  IL-4 and IL-15 promotion of virtual memory CD8+ T cells is determined by genetic background.

Authors:  Pulak Tripathi; Suzanne C Morris; Charles Perkins; Allyson Sholl; Fred D Finkelman; David A Hildeman
Journal:  Eur J Immunol       Date:  2016-08-16       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.